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Abstract
In order to establish infections within the mammalian host, pathogens must protect themselves against toxic reactive
oxygen species produced by phagocytes of the immune system. The fungal pathogen Histoplasma capsulatum infects both
neutrophils and macrophages but the mechanisms enabling Histoplasma yeasts to survive in these phagocytes have not
been fully elucidated. We show that Histoplasma yeasts produce a superoxide dismutase (Sod3) and direct it to the
extracellular environment via N-terminal and C-terminal signals which promote its secretion and association with the yeast
cell surface. This localization permits Sod3 to protect yeasts specifically from exogenous superoxide whereas amelioration of
endogenous reactive oxygen depends on intracellular dismutases such as Sod1. While infection of resting macrophages by
Histoplasma does not stimulate the phagocyte oxidative burst, interaction with polymorphonuclear leukocytes (PMNs) and
cytokine-activated macrophages triggers production of reactive oxygen species (ROS). Histoplasma yeasts producing Sod3
survive co-incubation with these phagocytes but yeasts lacking Sod3 are rapidly eliminated through oxidative killing similar
to the effect of phagocytes on Candida albicans yeasts. The protection provided by Sod3 against host-derived ROS extends
in vivo. Without Sod3, Histoplasma yeasts are attenuated in their ability to establish respiratory infections and are rapidly
cleared with the onset of adaptive immunity. The virulence of Sod3-deficient yeasts is restored in murine hosts unable to
produce superoxide due to loss of the NADPH-oxidase function. These results demonstrate that phagocyte-produced ROS
contributes to the immune response to Histoplasma and that Sod3 facilitates Histoplasma pathogenesis by detoxifying host-
derived reactive oxygen thereby enabling Histoplasma survival.
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Introduction
Highly reactive oxygen metabolites are one of the primary
effector mechanisms used by the host immune system to control or
clear microbial infections. Initial host defenses against fungal
invaders rely on responses of innate immune cells, particularly
neutrophils (polymorphonuclear leukocytes; PMNs) and macro-
phages. These phagocytes produce reactive oxygen molecules
through activation of the NADPH-oxidase complex that generates
superoxide. Superoxide and the other reactive molecules derived
from it, including peroxide and hydroxyl radicals, are collectively
termed reactive oxygen species (ROS). These species can directly
damage macromolecules on or in the microbe leading to death of
the microbe [1]. Cytokine activation of macrophages during the
adaptive immune response enhances the ability of macrophages to
produce ROS and this correlates with increased ability to restrict
or kill microbes [2,3]. Since ROS molecules are highly toxic to
microbes, effective pathogens must avoid or neutralize phagocyte-
derived ROS in order to survive within the host. This is
particularly necessary for intracellular pathogens.
The yeast form of Histoplasma capsulatum is an intracellular
pathogen that successfully infects and parasitizes phagocytes. The
fungus is widespread in the Midwestern United States and
throughout Latin America. It is estimated that 200,000 infections
occur annually in the United States through inhalation of infectious
particles [4]. Macrophages efficiently ingest pathogenic Histoplasma
yeast cells, but are unable to killthe yeasts [5–7]. By itself, the innate
immune system is insufficient to clear the infection. With activation
of the adaptive immune response and the corresponding enhance-
ment of phagocyte antifungal defenses, most immunocompetent
individuals can restrict Histoplasma proliferation [8,9].
The mechanisms Histoplasma employs to avoid clearance by
innate immune cells are essential to its virulence. Histoplasma
survival in macrophages may result, in part, by the lack of an
oxidative burst from these phagocytes [5,10–12]. Activation of
macrophages by cytokines primes their production of ROS in
response to Histoplasma [5,12,13]. PMNs also participate in the
initial response to respiratory Histoplasma infection [14,15] and the
interaction of Histoplasma with these phagocytes triggers a
respiratory burst [16–19]. Nevertheless, Histoplasma yeast cells
are not killed despite ample ROS production adequate to kill other
fungi such as Candida [17–20]. How Histoplasma yeasts endure this
oxidative challenge and the factors enabling Histoplasma survival in
the face of phagocyte-derived ROS are unknown.
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recently examined the extracellular proteome of pathogenic-phase
Histoplasma cells [21]. From this, we identified three proteins
potentially involved in defending Histoplasma from ROS. One
protein is a predicted superoxide dismutase (Sod3) whose
expression is greatly enriched in pathogenic phase yeast cells
suggesting its importance to virulence. This extracellular protein is
distinct from other Histoplasma superoxide dismutases that have a
higher degree of similarity to cytoplasmic enzymes [21], suggesting
Sod3 functions in combating extracellular superoxide, such as that
which would be produced by phagocytes.
In this paper, we define the contribution of Sod3 to Histoplasma
pathogenesis and the role of host-derived reactive oxygen defenses.
To functionally test the role of Sod3, we created a Histoplasma
strain lacking the SOD3 gene. Our results demonstrate that Sod3 is
the major source of extracellular superoxide dismutase activity and
that Sod3 prevents superoxide-dependent killing of Histoplasma
yeast cells. In addition, we show that host control of Histoplasma
infection requires ROS production. These results identify Sod3 as
an essential virulence factor of Histoplasma and provide a
mechanistic explanation as to how Histoplasma survives ROS
generated by host phagocytes during infection.
Results
The Histoplasma SOD3 gene encodes an extracellular
superoxide dismutase
Proteomic analysis of the extracellular proteins produced by
pathogenic-phase Histoplasma cells identified a putative superoxide
dismutase [21]. The gene encoding this protein was designated
SOD3 to distinguish it from the intracellular Sod proteins, Sod1,
Sod2, and Sod4. The SOD3 locus contains a 771 base pair gene
comprised of two exons (GI: EEH08361.1). Previous work
demonstrated that the SOD3 gene is preferentially expressed by
Histoplasma pathogenic yeast cells compared to expression by non-
pathogenic mycelia. Furthermore, SOD3 is expressed during in
vivo infection consistent with a role in virulence [21]. In vitro, the
Sod3 protein is produced by yeasts during growth in rich (HMM)
and minimal (3M) media at 37uC with 5% CO2/95% air (data not
shown).
To validate the predicted SOD3 gene and to enable functional
analyses of Sod3, we created a mutant strain lacking the SOD3
gene. A deletion allele was created by replacement of the SOD3
coding region with a constitutively-expressed hygromycin resis-
tance gene (hph). Two kilobases of DNA sequence corresponding
to sequence immediately 59 and 39 of the SOD3 gene flanked the
hph cassette to serve as recombination substrates. The chromo-
somal locus was replaced with the deletion allele by allelic
exchange and the rare recombinants were isolated by successive
positive and negative selections [22]. We confirmed deletion of the
SOD3 gene by PCR analysis using primers specific for either the
wild-type or the deletion allele (Figure 1A). Whereas SOD3 coding
region-specific primers detect a 770 base pair product from the
parental strain (SOD3(+)), no SOD3 coding region is amplified
from the SOD3-deletion (sod3D) strain. In contrast, a PCR product
corresponding to the hph-marker was only amplified from the
sod3D strain as expected for replacement of the wild-type locus
with the deletion allele. Amplification of the RPS15 gene indicates
that the genomic DNA used was competent for PCR amplifica-
tion. The sod3D strain has identical colony morphology and grows
at an equal rate to the SOD3(+) strain in culture, in both HMM
and 3M media (data not shown).
Culture filtrate from the sod3D strain demonstrates that SOD3
encodes the major extracellular superoxide dismutase activity
produced by Histoplasma yeasts. To measure superoxide dismutase
activity, we used an indirect assay of superoxide anion through
superoxide-dependent reduction of the water soluble tetrazolium
salt WST-1 [23]. Xanthine oxidase and hypoxanthine were used
to generate the superoxide in this in vitro system. Five micrograms
of total culture filtrate protein from SOD3(+) and sod3D strains
were added to the superoxide generating/WST-1 system
(Figure 1B). Culture filtrate from the SOD3(+) strain substantially
decreased the rate of WST-1 reduction, indicating depletion of
superoxide by the Sod3-containing culture filtrate. In contrast,
inhibition of WST-1 reduction by culture filtrate from the sod3D
strain is nearly identical to the buffer control, indicating very little
destruction of superoxide by the sod3D culture filtrate. Expression
of the predicted SOD3 genomic DNA in the sod3D mutant (sod3D/
SOD3) fully complements the loss of superoxide dismutase activity
in sod3D culture filtrate. These data indicate that SOD3(+)
Histoplasma yeasts produce soluble extracellular superoxide dis-
mutase activity and that the SOD3 gene product is responsible for
the majority of this superoxide dismutase activity.
Bioinformatic analyses suggested Sod3 is more similar to Cu/Zn
Sod proteins than to Fe/Mn-type enzymes and we functionally
confirmed this by testing Sod3-dependent superoxide dismutation
following copper depletion. Culture filtrates from Sod3-producing
and Sod3-deficient strains were treated with 50 mM diethyldithio-
carbamate (DDC), a copper chelator, to remove copper ions from
Sod3 and the resultant culture filtrates tested for superoxide
dismutase activity (Figure 1C). Without DDC treatment, culture
filtrate from SOD3(+) yeasts inhibits WST-1 reduction by nearly
60% compared to the buffer control due to superoxide dismutase
activity. However, DDC treatment effectively negates the inhibi-
tion caused by culture filtrate from the SOD3(+) strain, indicating
loss of superoxide dismutase activity. DDC treatment of culture
filtrate from the SOD3(+) strain is similar to untreated culture
filtrate from the sod3D mutant, consistent with loss of Sod3 activity
due to Cu
++ chelation (Figure 1C). Culture filtrate from the sod3D
mutant similarly lacks dismutase activity after treatment with
DDC. Replenishing Cu
++ ions to DDC-treated SOD3(+) culture
filtrate largely restores superoxide dismutase activity (44%
inhibition of WST-1 reduction compared to 57% inhibition with
untreated SOD3(+) culture filtrate). These results demonstrate that
Sod3 depends on copper for enzymatic activity and classifies it as a
Cu/Zn-type superoxide dismutase.
Author Summary
Histoplasma capsulatum is a fungal pathogen that is
endemic to the Mississippi and Ohio River valleys. An
estimated 200,000 infections occur annually in the United
States. Histoplasma is adept at surviving within both
neutrophils and macrophages, which normally kill fungal
cells by producing reactive oxygen molecules that are
toxic to microbes. In this study, we demonstrate the role of
a superoxide dismutase enzyme (Sod3) produced by
Histoplasma cells and we show that it enables Histoplasma
to survive these reactive oxidative molecules produced by
the host. We show that Histoplasma directs the Sod3
protein to the surface of yeast cells and into the
extracellular environment, positioning it to destroy extra-
cellular superoxide produced by neutrophils and macro-
phages. Our results highlight the importance of reactive
oxygen produced by immune cells and define the
mechanism by which Histoplasma survives these immune
defenses and establishes infections in its host.
Histoplasma Defense against Host Reactive Oxygen
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cells
Alignment of Sod3 protein sequences derived from the
sequenced Histoplasma genomes (G186A, G217B, and NAm1)
highlights regions of high conservation at the N- and C-termini
(Figure 2A). The N-terminus of Sod3 has a predicted signal
peptide (amino acids 1–21) that potentially directs the protein into
the canonical eukaryotic secretion pathway consistent with Sod3’s
localization to the extracellular environment [21]. In contrast to
the variable sequence identity found throughout the central region
of the protein among Histoplasma Sod3 orthologs (which includes
the core domain shared among enzymes with superoxide
dismutase catalytic activity), the C-terminal 24 amino acids are
100% identical suggesting conservation of an important function
beyond superoxide dismutase activity. Further inspection of the C-
terminus identifies a potential glycophosphatidyl inositol (GPI)
attachment signal with a putative omega site at residue 205. GPI
signals characterize a number of Saccharomyces cerevisiae and Candida
albicans cell wall proteins in which the GPI anchor is thought to be
subsequently cleaved and the protein covalently attached to the
cell wall [24,25]. These two motifs potentially direct secretion of
Sod3 from yeast cells and may provide for its association with the
yeast cell wall in addition to its observed presence in the soluble
culture filtrate.
To determine if a portion of Sod3 is associated with the
Histoplasma yeast cell wall, yeast cells and their corresponding
culture filtrates were tested for superoxide dismutase activity.
Addition of cells and culture filtrates to the superoxide generating/
WST-1 system showed that both culture filtrates and cells prevent
superoxide-dependent reduction of WST-1 (Figure 2B). Com-
pared to the buffer control, cell-associated Sod activity inhibits
WST-1 reduction by 61%. A comparable amount of culture
filtrate inhibits WST-1 reduction by 60%. Thus, approximately
50% of the total extracellular Sod activity is associated with the cell
and 50% is found in the soluble fraction. Sod activity associated
with sod3D cells and their culture filtrates inhibit WST-1 reduction
by 26% and 27%, respectively, indicating that the majority of the
cell-associated and cell-free Sod activity is attributable to cell-
associated and cell-free Sod3 protein.
To determine if the putative N-terminal signal peptide of Sod3
functions as a secretion signal, we tested whether the N-terminus
could direct secretion of a normally cytosolic protein. Sequence
encoding the first 26 amino acids of Sod3 was fused to a gfp coding
sequence which had a C-terminal FLAG epitope to allow
monitoring of the GFP protein localization by immunoblotting.
Expression of gfp lacking the N-terminal Sod3 residues causes GFP
accumulation in the cytosol of yeast cells as determined by
fluorescence microscopy (data not shown) and by immunoblotting
of cellular lysates (Figure 2C). On the other hand, GFP protein
possessing the Sod3 N-terminal residues is secreted into the culture
filtrate and is effectively absent from the cytosolic fraction
(Figure 2C). These results demonstrate that the Sod3 N-terminal
residues encode a signal peptide that is sufficient to direct protein
secretion from yeast cells.
As yeast cells have significant Sod3 activity, we examined the
role of the putative GPI signal in mediating cell-association of
Sod3. To track the localization of Sod3, sequence encoding the
FLAG epitope was inserted into the SOD3 cDNA at nucleotide 79
of the coding sequence thereby preserving the Sod3 signal peptide
for secretion. Downstream of the FLAG epitope, the SOD3
sequence encoded either Sod3 with the putative GPI attachment
signal (nucleotides 79–693 encoding amino acids 27–231) or Sod3
without the GPI signal (nucleotides 79–615 encoding amino acids
27–205). Each construct was transformed into sod3D yeasts. To
Figure 1. Histoplasma Sod3 encodes an extracellular Cu
++-
dependent superoxide dismutase. (A) PCR validation of deletion of
the SOD3 gene. Genomic DNA from the SOD3(+) parental strain (WU8)
and the sod3D strain (OSU13) were tested by PCR for the ribosomal
subunit gene RPS15, the wild-type SOD3 gene, and the mutant allele
marked with the hygromycin resistance gene (hph). (B) Superoxide
dismutase activity in culture filtrates harvested from SOD3(+) (OSU45),
sod3D (OSU15), and the sod3D/SOD3 complemented (OSU49) strains.
Detection of superoxide was determined through superoxide-depen-
dent reduction of the WST-1 tetrazolium dye after generation of
superoxide using hypoxanthine and xanthine oxidase. Reduction of
WST-1 was monitored by absorbance at 438 nm. Buffer or culture
filtrates contained 5 mg ovalbumin or total culture filtrate protein,
respectively. Asterisks represent significant difference (*** p,0.001) in
the inhibition of WST-1 reduction between SOD3(+) and sod3D culture
filtrates. Data shown is representative of three independent exper-
iments, each performed with triplicate samples. (C) Sod3 activity
following Cu
++ depletion. Culture filtrates containing 5 mg total protein
from SOD3(+) (OSU45) and sod3D (OSU15) strains were tested for their
ability to inhibit WST-1 reduction by superoxide before (no chelator),
after Cu
++ depletion (+DDC), and after subsequent repletion with
50 mM Cu
++ (+CuSO4). Values represent relative inhibition of WST-1
reduction by culture filtrate samples (n=3) compared to buffer controls
treated in parallel. Asterisks represent significant differences from
SOD3(+) culture filtrates (* p,0.05, ** p,0.01).
doi:10.1371/journal.ppat.1002713.g001
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reduced cell-association, yeast cells and their corresponding
culture filtrates were assayed for their ability to inhibit WST-1
reduction corresponding to superoxide dismutase activity. Expres-
sion of FLAG-tagged Sod3 protein yields both cell-free and cell-
associated superoxide dismutase activity similar to the ratio
observed for SOD3(+) yeast cells (Figure 2D). Deletion of the
GPI signal from Sod3 significantly decreases cell-associated Sod
activity, approaching background levels of sod3D mutant yeasts
(18% and 12% inhibition of WST-1 reduction, respectively). This
is consistent with diminished retention of cell-associated Sod3
when the GPI signal is removed.
From this data alone, the possibility that loss of the C-terminal
GPI signal causes misfolding of Sod3, either resulting in the
protein being degraded within the cell or being transported to the
extracellular fraction in an inactive form, cannot be ruled out. To
address this, we examined the superoxide dismutase activity in
matching culture filtrates from these yeast cells. We found that the
decrease in cell-associated Sod3 is accompanied by an increase in
soluble Sod3 activity in the culture filtrate (54–57% inhibition of
WST-1 reduction compared to 26–27% inhibition by GPI signal-
containing Sod3). As further evidence of the redirection of Sod3
from the cell surface to the soluble fraction in the absence of the
GPI signal, immunoblotting of culture filtrates shows approxi-
mately 2.4-fold more Sod3 protein is released into the culture
filtrate without the GPI signal than when the GPI signal is present
(Figure 2D). Attempts to directly measure cell-associated Sod3
protein by immunoblotting failed despite treatment of the cell wall
fraction with reductants (dithiothreitol), ionic detergent (SDS), or
glycanases (zymolyase and chitinase) and combinations of each to
release soluble Sod3 from insoluble cell wall material (data not
shown). Nonetheless, depletion of cell-associated Sod3 activity and
Figure 2. N-terminal and C-terminal signals direct extracellular localization of Sod3. (A) Schematic of the Sod3 protein highlighting the
predicted signal peptide (SP) and the glycophosphatidyl inositol anchor (GPI) signal motifs. Numbers represent amino acid residues in the Sod3
protein. Shading beneath the Sod3 protein indicates amino acid sequence similarity between G186A, G217B and NAm1 Sod3 proteins ranging from
dark (.90% sequence identity) to light (,50% identity). (B) Relative Sod3 activity associated with the yeast cell and soluble extracellular fraction.
Superoxide dismutase activities were determined by inhibition of superoxide-dependent WST-1 reduction in the presence of 1610
8 yeasts (cell-
associated) or the corresponding culture filtrate (soluble) of SOD3(+) (OSU45) and sod3D (OSU15) strains (n=3, each). Inhibition of WST-1 reduction
was normalized to reactions in the absence of yeasts or culture filtrate. Asterisks represent significant differences (p,0.001) from SOD3(+) samples.
(C) Determination of the localization of GFP when fused to the N-terminus of Sod3. Extracellular or intracellular GFP localization was determined by a-
FLAG immunoblot of culture filtrates or cellular lysates from Histoplasma yeast strains expressing FLAG epitope-tagged GFP (GFP:FLAG; OSU88) or
GFP with the first 26 amino acids of Sod3 (Sod31–26:GFP:FLAG; OSU102). Cellular lysates were also tested for a-tubulin to demonstrate equal loadings.
(D) Localization of Sod3 activity after removal of the C-terminal 26 amino acids. Cell-associated and soluble superoxide dismutase activities of
Histoplasma yeasts were determined using 1610
8 intact yeasts or their corresponding culture filtrates, respectively. Samples were collected from
SOD3(+) (OSU45), sod3D (OSU15), and yeasts expressing full length Sod3 (sod3D/FLAG:SOD3; OSU116) or Sod3 lacking the putative GPI signal (sod3D/
FLAG:SOD3DGPI; OSU117). Results were normalized to uninhibited reactions and plotted as the proportion of total inhibitory activity. Asterisks
represent significant difference from full length Sod3 (** p,0.01, *** p,0.001). Relative quantitation of Sod3 in culture filtrates was determined by a-
FLAG immunoblot and is indicated numbers below.
doi:10.1371/journal.ppat.1002713.g002
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GPI signal is removed indicates the GPI signal promotes cell-
association of a portion of the total secreted Sod3.
Sod3 protects specifically against extracellular reactive
oxygen
The extracellular localization of Sod3 predicts Sod3 is produced
to combat exogenous but not intracellular superoxide. Indeed,
Histoplasma yeasts express additional Sod proteins homologous to
intracellular superoxide dismutase enzymes and these are more
appropriately positioned to detoxify endogenous superoxide such
as would be generated from aerobic respiration. The Histoplasma
SOD1 gene encodes a protein homologous to Cu/Zn superoxide
dismutase enzymes commonly found in the cytosol of eukaryotes
[21]. To determine the specificity of Sod3 and Sod1 for
extracellular and intracellular superoxide, respectively, we com-
pared the ability of strains deficient for Sod3 and strains depleted
of Sod1 for their ability to survive intracellular superoxide stress.
To enable these tests, we depleted Sod1 activity from Histoplasma
yeasts by RNA interference (RNAi). Depletion of Sod1 function in
a GFP-fluorescent RNAi sentinel strain [26] was initially
determined by reduced GFP fluorescence caused by co-targeting
gfp and SOD1 sequence (Figure 3A). Two independent RNAi lines
were created in which the fluorescence of the GFP sentinel is
reduced 47%–54%, which is indicative of knock-down of Sod1
function. To confirm depletion of Sod1 function, yeast cellular
lysates were tested for superoxide dismutase activity. While
deletion of the SOD3 locus removes extracellular superoxide
dismutase activity (Figure 1B), deletion of SOD3 does not reduce
cytosolic superoxide dismutase activity compared to isogenic
SOD3(+) yeasts (51% and 50% inhibition of WST-1 reduction,
respectively; Figure 3A). However, depletion of Sod1 activity by
RNAi diminishes cytosolic superoxide dismutase activity com-
pared to the isogenic gfp-RNAi and parental gfp(+) strains (21%
and 13% compared to 46% and 45% inhibition of WST-1
reduction, respectively). Thus, loss of Sod3 specifically affects
Figure 3. Histoplasma Sod3 does not alleviate intracellular oxidative stress. (A) Depletion of intracellular superoxide dismutase activity by
SOD1-RNAi but not by loss of Sod3. RNAi-based depletion of Sod1 was done in a GFP-expressing Histoplasma strain (OSU22). GFP fluorescence is
shown in colony images of a strain in which gfp was not targeted (gfp(+); OSU103), gfp alone was targeted (gfp-RNAi; OSU104) or two independent
isolates in which gfp and SOD1 were co-targeted (gfp:SOD1-RNAi; OSU105). Numbers below the images indicate relative GFP fluorescence.
Intracellular superoxide dismutase activity was determined by inhibition of WST-1 reduction using 5 mg of cellular lysate protein from SOD3(+)
(OSU45), sod3D (OSU15), and the RNAi strains and results plotted relative to uninhibited reactions using 5 mg BSA. Non-significant (ns) and significant
(*** p,0.001) differences between SOD3(+) and sod3D or between the SOD1(+) strain (gfp(+)) and the gfp-RNAi or SOD1-RNAi strain are indicated
above the columns. (B–D) Inhibition of yeast growth by increased intracellular reactive oxygen. Liquid growth of SOD3(+) (OSU45), sod3D (OSU15),
Sod1-proficient (gfp-RNAi; OSU104), and SOD1-RNAi (gfp:SOD1-RNAi; OSU105) strains was determined by optical density of cultures measured at
595 nm. Intracellular reactive oxygen was increased in yeasts by addition of 5 mM( C)o r1 0mM( D) paraquat. Growth curve points represent the mean
optical density of replicate cultures (n=3).
doi:10.1371/journal.ppat.1002713.g003
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Conversely, depletion of Sod1 specifically reduces intracellular
superoxide dismutase activity.
Sod1-depleted and Sod3-deficient strains were tested for their
sensitivities to intracellular superoxide to ascertain their roles in
protecting against intracellular superoxide stress. Yeast cells were
grown in liquid culture with increasing amounts of paraquat,
which interacts with intracellular redox systems and the mito-
chondrial respiratory chain to cause increased formation of
superoxide [27,28]. Paraquat treatment of yeast cells causes a
dose-dependent decrease in growth as measured by the optical
density of yeast cells, indicating paraquat is detrimental to
Histoplasma cells (Figure 3B–D). Histoplasma yeasts are susceptible
to paraquat at concentrations of 5 mM and greater, and yeast cells
lacking Sod3 show no enhanced sensitivity compared to yeasts
producing Sod3 (Figure 3C–D). In contrast, yeast cells depleted of
Sod1 show greater sensitivity to paraquat than isogenic cells
expressing normal amounts of Sod1. Thus, Sod1 contributes to
alleviation of intracellular superoxide stress, but Sod3 does not
mitigate intracellular superoxide. These results are consistent with
Sod3 specifically functioning in combating exogenous oxidative
stress.
To test the role of Sod3 in protecting Histoplasma from
exogenous superoxide, yeast cells were challenged in vitro with
superoxide. To generate superoxide in vitro, graded amounts of
xanthine oxidase were added to yeast suspensions in Tris buffer
with excess hypoxanthine; the amount of superoxide proportion-
ally increases with the concentration of xanthine oxidase enzyme
(Figure S1). Parental SOD3(+) yeasts largely survive the in vitro
superoxide challenge (Figure 4A). However, yeasts lacking Sod3
are unable to survive superoxide challenge; only 23–35% of sod3D
yeasts survive challenge with superoxide levels at which the Sod3-
producing yeasts exhibit greater than 95% survival. Challenge of
yeasts with the highest level of superoxide that kills roughly 20% of
SOD3(+) yeasts, kills over 85% of the sod3D mutant yeasts.
Complementation of the sod3D mutant restores protection against
superoxide challenge to SOD3(+) levels. Interestingly, the impaired
survival of Sod3-deficient Histoplasma yeasts resembles the degree
of killing of Candida albicans yeasts by superoxide (Figure 4A). These
results demonstrate that Sod3 protects Histoplasma yeasts from
exogenous superoxide.
Superoxide is only one reactive oxygen species with potentially
lethal effects on Histoplasma yeasts. Spontaneous dismutation of the
superoxide that is generated by the xanthine oxidase/hypoxan-
thine system could also expose yeasts to peroxide stress that could
affect yeast cell viability. To determine if peroxide contributes to
the enhanced superoxide killing of sod3D cells, yeasts were
challenged in vitro with different concentrations of hydrogen
peroxide (0 mM to 4 mM). Increasing the concentration of
hydrogen peroxide kills an increasing proportion of Histoplasma
yeasts (Figure 4B). However, Sod3-expressing and Sod3-deficient
yeast have very similar susceptibilities to hydrogen peroxide. These
results indicate that peroxide, a potential reactive oxygen
derivative of superoxide, does not significantly contribute to the
increased killing of sod3D mutant yeast cells during challenge with
superoxide.
Sod3 protects Histoplasma yeast cells from phagocyte-
derived reactive oxygen
The primary source of exogenous reactive oxygen encountered
by Histoplasma during infection is that produced by host phagocytic
cells. Of these cells, PMNs are notorious for their strong oxidative
burst in response to pathogens. To test if Sod3 defends Histoplasma
yeasts from killing by PMNs, SOD3(+) and sod3D mutant yeasts
were co-incubated with human PMNs. SOD3(+) yeasts largely
survive the encounter with PMNs exhibiting 94% and 81%
viability after 2 hours and 4 hours, respectively (Figure 5A).
Without Sod3, Histoplasma yeast cells are efficiently killed by
PMNs; only 50% of the sod3D yeast cells remain viable after
2 hours and viability drops to 31% by 4 hours. As was observed
with in vitro sensitivity to superoxide challenge, PMN killing of
sod3D yeast cells mirrors the susceptibility of Candida to PMN
killing (Figure 5A).
The fungicidal effect on Sod3-deficient yeasts depends on PMN
production of reactive oxygen. Suppression of the NADPH-
oxidase complex by treatment of PMNs with 10 mM diphenylene
iodinium (DPI; [29]) substantially reduces PMN killing of
Histoplasma and Candida yeast cells (Figure 5B). Survival of sod3D
yeasts when co-incubated with PMNs improves from 26% to 89%
when the NADPH-oxidase is inhibited, restoring yeast viability to
that of Sod3-producing Histoplasma yeasts. Impairing NADPH-
oxidase function similarly enhances Candida survival (Figure 5B).
Figure 4. Sod3 protects Histoplasma yeast cells from exogenous
superoxide in vitro. (A) Survival of yeast cells following challenge
with superoxide. Yeasts were incubated in increasing amounts of
superoxide generated by addition of increasing amounts of xanthine
oxidase to hypoxanthine. SOD3(+) (OSU45), sod3D (OSU15), sod3D/SOD3
(OSU49), and Candida albicans yeasts were incubated for 4 hours at
37uC after which viable colony forming units (cfu) were determined.
Results are plotted as relative yeast survival compared to viable cfu of
yeasts incubated in the absence of superoxide (0 mU/mL xanthine
oxidase). Results represent the mean 6 standard deviations from 3
replicate challenges per strain. Asterisks indicate significant differences
(** p,0.01, *** p,0.001) from the SOD3(+) strain. (B) Sensitivity of
Histoplasma yeasts to hydrogen peroxide. Increasing amounts of
hydrogen peroxide were added to Histoplasma yeasts (n=3 for each
strain) at 37uC and the viability of yeasts after 4 hours was determined
by enumeration of viable cfu. Results are plotted as relative yeast
survival compared to viable cfu of yeasts incubated in the absence of
peroxide (0 mM hydrogen peroxide). Data is representative of 3
independent experiments.
doi:10.1371/journal.ppat.1002713.g004
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does DPI impair PMN viability (Figure S2A, [30]).
The protective effects of DPI or Sod3 on Histoplasma viability
derive from their ability to decrease toxic reactive oxygen
molecules, either by preventing superoxide production or by
dismuting PMN-produced superoxide, respectively. To demon-
strate this, we measured reactive oxygen levels produced during
co-incubation of yeasts and PMNs with luminol (Figure 5C). In the
absence of yeast cells, highly reactive PMNs gradually produce
reactive oxygen species as indicated by the slow rate of increasing
luminol luminescence. Addition of both SOD3(+) and sod3D
Histoplasma cells stimulates rapid production of reactive oxygen by
the PMNs, confirming PMNs react to Histoplasma yeasts. While
reactive oxygen species persist when sod3D yeast cells are added,
the reactive oxygen quickly disappears in the presence of yeast cells
producing Sod3. Addition of DPI abrogates the luminol lumines-
cence triggered by both SOD3(+) and sod3D strains, consistent with
its ability to inhibit the NADPH-oxidase. Together these data
show that although yeast interaction with PMNs triggers
production of fungicidal reactive oxygen, Histoplasma Sod3
eradicates the superoxide generated thereby providing for
increased yeast survival.
In addition to encountering PMNs, Histoplasma also infects
macrophages during infection of the host. To explore the role of
Sod3 in this interaction, we measured the survival of Histoplasma
yeast cells following infection of both resting and activated
macrophages. 80% and 93% of SOD3(+) yeast cells remain viable
after infection of resting macrophages at 2 and 4 hours (Figure 6A).
The absence of Sod3 results in a small but significant decrease in
sod3D yeast viability compared to SOD3(+) yeasts consistent with
minimal production of reactive oxygen by resting macrophages in
response to Histoplasma. When macrophages are activated with
IFNc and TNFa to enhance production of reactive oxygen species,
SOD3(+) Histoplasma yeasts continue to survive (Figure 6B). How-
ever, the viability of sod3D yeasts in these activated macrophages is
considerably reduced with only 62% and 41% surviving at 2 and
4 hours. Macrophages treated with IFNc, but not TNFa, similarly
demonstrate anti-Histoplasma activity, but the degree of killing is
enhanced by the presence of both cytokines (data not shown).
Interaction of Candida yeasts with either resting or activated
macrophages decreases Candida viability (Figure 6A–B).
Since production of superoxide is not the only antimicrobial
mechanism in the macrophage arsenal, we tested survival of yeast
cells in macrophages that are unable to produce superoxide.
Inhibition of the NADPH-oxidase complex with DPI prevents
killing of Histoplasma sod3D and Candida yeasts by activated
macrophages, indicating that the majority of the macrophage
fungicidal activity at 4 hours post-infection requires the produc-
tion of reactive oxygen compounds (Figure 6C). As with PMNs,
treatment of phagocytes with 10 mM DPI does not impair host cell
viability (Figure S2B). As independent evidence that the outcome
of the interaction between yeasts and macrophages involves
oxidative killing, we monitored the macrophage oxidative burst
during infection with Histoplasma yeasts (Figure 6D). In the absence
of fungi, both resting and activated macrophages produce little
reactive oxygen. When infected with Histoplasma yeasts, resting
macrophages produce negligible reactive oxygen, indicating yeasts
do not stimulate an oxidative burst in these cells (data not shown).
This is not the case with activated macrophages where Histoplasma
yeasts trigger an initial burst of reactive oxygen within 5 minutes
that peaks 10–20 minutes after addition of yeasts (Figure 6D).
Considerably less reactive oxygen is detected (65% decrease) if the
infecting yeasts produce Sod3 than if the yeasts lack Sod3,
consistent with Sod3 destroying superoxide. Thus, activated
Figure 5. Sod3 protects Histoplasma yeasts from PMN-derived
reactive oxygen. (A) Survival of yeasts after infection of human PMNs.
SOD3(+) (OSU45), sod3D (OSU15) and Candida albicans yeasts were
added to PMNs at a multiplicity of infection (MOI) of 1:10. Yeast survival
was determined by enumeration of viable cfu after 2 and 4 hours of co-
incubation of yeasts with PMNs at 37uC. Results are plotted as relative
yeast survival (mean 6 standard deviation of 3 replicates) compared to
viable cfu of yeasts incubated in the absence of PMNs. Significantly
decreased survival compared to SOD3(+) yeasts is indicated by asterisks
(** p,0.01). (B) Inhibition of yeast killing by PMNs upon inactivation of
the NADPH-oxidase. Yeasts were added to PMNs (+ PMNs) and incubated
for 4 hours at 37uC and viable cfu were determined. 10 mM diphenylene
iodinium (DPI) was added to some assays to inactivate the NADPH-
oxidase. Results indicate relative yeast survival (mean 6 standard
deviation of 3 replicates) compared to viable cfu of yeast incubated in
the absence of PMNs (no PMNs). Significant (** p,0.01) or non-
significant (ns) reduction in survival compared to yeast in the absence of
PMNs is indicated above the respective columns. (C) Reactive oxygen
production by PMNs in response to Histoplasma yeasts. Histoplasma
yeasts were added to PMNs at an MOI of 1:1 in the presence of the
luminol ROS-detection reagent and the luminol luminescence measured
over time. PMNs and yeasts were co-incubated in the presence (open
symbols)orabsence(closedsymbols)of10 mMDPItoinhibit theNADPH-
oxidase. Data points represent the mean luminescence (n=3).
doi:10.1371/journal.ppat.1002713.g005
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Histoplasma yeasts, but yeast-generated Sod3 destroys these reactive
compounds and this ROS diminution correlates with enhanced
survival of Histoplasma in phagocytes.
Sod3 promotes Histoplasma virulence in vivo
To determine the contribution of Sod3 to Histoplasma virulence
in vivo, we measured the ability of yeasts lacking Sod3 function to
infect murine tissues. As indicators of respiratory and systemic
disease, the fungal burden was determined in lung and spleen
tissues, respectively, following intranasal delivery of a sublethal
inoculum. SOD3(+) yeasts infect and replicate within the lung
tissue, increasing the fungal burden 400-fold through day 8. The
onset of cell-mediated immunity begins to clear SOD3(+) yeasts
from the lung after day 12 (Figure 7A). With SOD3(+) Histoplasma
yeasts, dissemination to the spleen occurs by day 4 and rapidly
increases in this tissue (Figure 7B). As observed in the lung, the
fungal burden begins to clear in the spleen after day 12. In contrast
to SOD3(+) yeasts, the population of sod3D yeasts initially decreases
within the lung through day 4 without the protective function of
Sod3 (Figure 7A). Although there is some expansion of sod3D
yeasts between day 4 and day 8, the number of mutant yeasts
barely increase above the inoculum level and then shows rapid
clearance starting at day 12. Dissemination of sod3D yeasts from
the lung to the spleen is nearly undetectable, most likely as a
consequence of the substantially diminished number of sod3D
yeasts in the lung (Figure 7B). Complementation of the sod3D
mutant by expression of SOD3 genomic DNA, restores the ability
of yeasts to survive and replicate in the lung (Figure 7A), as well as
dissemination to the spleen (Figure 7B).
Lung tissue pathology caused by Histoplasma infection correlates
with lung colonization by Sod3-expressing and Sod3-deficient
strains. At 4 days post-infection, lesions are more pronounced in
lungs infected with SOD3(+) yeasts than with sod3D yeasts
(Figure 7C and Figure S3A). In SOD3(+)-infected lungs, more
inflammatory foci are present (1–13 per section) with thick collars
of inflammatory cells composed of PMNs with fewer alveolar
macrophages and lymphocytes (Figure 7C). Yeasts are associated
with the inflammatory foci and their numbers correlate with
inflammation severity. In contrast, inflammatory foci are rare (0–2
per section) with sparse cellular infiltrates in sod3D-infected lungs
(Figure 7C). Sod3-deficient yeasts are rarely observed consistent
Figure 6. Sod3 protects Histoplasma yeasts from ROS produced by activated macrophages. (A–B) Survival of yeasts after infection of
resting (A) or cytokine-activated (B) murine macrophages. SOD3(+) (OSU45), sod3D (OSU15) and Candida albicans yeasts were added to resident
peritoneal macrophages at an MOI of 1:50. Yeast survival was determined by enumeration of viable cfu after 2 and 4 hours of co-incubation of yeasts
with macrophages at 37uC. In (B), 10 U TNFa and 100 U IFNc were added to macrophages 24 hours prior to infection to enhance ROS production.
Results are plotted as relative yeast survival (mean 6 standard deviation of 3 replicates) compared to viable cfu of yeasts incubated in the absence of
macrophages. Significantly decreased survival compared to SOD3(+) yeasts is indicated by asterisks (* p,0.05, ** p,0.01, *** p,0.001). (C)
Prevention of yeast killing by macrophages after inhibition of the NADPH-oxidase. Yeasts were added to resting and to IFNc/TNFa-activated
macrophages and incubated for 4 hours at 37uC in the absence or presence of 10 mM diphenylene iodinium (DPI) and viable cfu were determined.
Results indicate relative yeast survival (mean 6 standard deviation of 3 replicates) compared to viable cfu of yeasts incubated in the absence of
macrophages. Significant (** p,0.01) or non-significant (ns) reduction in survival compared to yeasts in the absence of macrophages is indicated
above the respective columns. (D) Reactive oxygen production by activated macrophages in response to Histoplasma yeasts. Histoplasma yeasts were
added to resting or activated macrophages at an MOI of 1:1 in the presence of the luminol ROS-detection reagent and the luminol luminescence
measured over time. Macrophages and yeasts were co-incubated in the presence (open symbols) or absence (closed symbols) of 10 mM DPI to inhibit
the NADPH-oxidase. Data points represent the mean luminescence (n=3).
doi:10.1371/journal.ppat.1002713.g006
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that are present are presumably within macrophages. By 8 days
post-infection, when SOD3(+) fungal burdens are approaching
their maximal level, thick collars of inflammatory cells (primarily
macrophages and lymphocytes with fewer neutrophils) surround
most blood vessels and/or bronchioles (Figure S3B). Interstitial
myxedema and congestion is present with inflammation extending
into the parenchyma. In sod3D-infected lungs at 8 days, fewer and
less dense inflammatory foci are present. Thus, inflammation
severity and tissue pathology, as indicators of disease, closely
parallel the fungal burden established by Sod3-expressing and
Sod3-deficient yeasts in vivo.
To determine if establishment of lethal histoplasmosis requires
Sod3, mice were inoculated with a lethal dose of Histoplasma
SOD3(+) and sod3D yeasts. Mice infected with SOD3(+) and Sod3-
complemented (sod3D/SOD3) strains have a median survival time
of 5.5 and 5 days, respectively (Figure 8). In contrast, nearly all
mice infected with the sod3D strain survive through two weeks
(Figure 8) and appear to have fully recovered from the high
inoculum as they show no adverse symptoms and have regained or
surpassed their initial body weight (data not shown). Thus, the
protective effects of Sod3 are required for Histoplasma to establish
both lethal and sublethal infections in vivo. The differing fungal
burdens, lung pathology, and host survival determined for Sod3-
Figure 7. Histoplasma virulence in vivo requires Sod3. (A) Kinetics of sublethal lung infection by Histoplasma. Wild-type C57BL/6 mice were
intranasally infected with approximately 1610
4 SOD3(+) (OSU45), sod3D (OSU15), or sodD/SOD3 (OSU49) Histoplasma yeasts. At 4 day intervals post-
infection, the fungal burden in lungs was determined by quantitative platings for Histoplasma cfu. (B) Kinetics of dissemination following lung
infection with Histoplasma. At each time point, organs were harvested and the fungal burden in spleen tissue was determined by quantitative
platings for cfu. In (A) and (B), each data point represents cfu counts per organ from an individual animal (n=5 per time point) and horizontal bars
represent the mean fungal burden. Asterisks indicate significant differences at each time point from animals infected with SOD3(+) organisms
(* p,0.05, ** p,0.01, *** p,0.001). The actual inoculum dose is shown in graphs at day 0. The limit of detection is 100 cfu for lungs and 60 cfu for
spleen tissue. (C) Inflammation and pathology of lung tissue following Histoplasma infection. Wild-type C57BL/6 mice were infected with SOD3(+)
(OSU45), sod3D (OSU15), or sodD/SOD3 (OSU49) yeast and at 4 days post-infection, lungs were harvested and sections stained with hematoxylin and
eosin. Arrowheads indicate detectable clusters of yeast cells. Scale bars represent 50 mm.
doi:10.1371/journal.ppat.1002713.g007
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essential for the full virulence of Histoplasma in vivo.
The virulence attenuation due to loss of Sod3 function contrasts
with the full virulence of yeasts depleted of the intracellular
superoxide dismutase, Sod1. Depletion of Sod1 by RNAi (Figure 3)
from Histoplasma yeasts does not impair lung infection; the gfp-
RNAi and gfp:SOD1-RNAi strains establish comparable fungal
burdens in lungs throughout acute and clearing stages of infection
(Figure S4). These results demonstrate that Histoplasma virulence
specifically requires extracellular (Sod3) superoxide dismutase
function.
Virulence in the animal model reflects the summation of
multiple aspects of the immune response in control of Histoplasma
yeasts. To clearly define the mechanism of the attenuation of
sod3D yeasts in vivo, we tested the effect of specifically eliminating
superoxide production by the host. Infections were established in
mice lacking a functional phagocyte NADPH-oxidase complex
(Phox) due to mutation of the p47
Phox subunit [31]. If the reduced
virulence of sod3D yeasts in vivo results from inability to survive
host-produced reactive oxygen, eliminating this host defense
mechanism would restore the virulence of sod3D yeasts. In
Phox(+/+) mice, SOD3(+) Histoplasma yeasts survive and establish
respiratory infection as evidenced by the increasing fungal burdens
over the first 8 days (Figure 9A). Although the magnitude of the
fungal burdens in the lungs of these Phox(+/+) mice are less than
that for experiments in Figure 7 due to different susceptibilities of
wild-type mice among vendors, the upward trend in fungal burden
is repeated in these mice that are isogenic with the Phox(2/2)
mice. Similar to earlier results, at least half of the sod3D yeasts are
killed in Phox(+/+) mice, demonstrating the Sod3 requirement for
Histoplasma survival (Figure 8A). However, in Phox(2/2) mice
unable to generate superoxide, SOD3(+) and sod3D yeasts survive
and replicate in lung tissue better than in Phox(+/+) hosts. In the
Phox(2/2) hosts unable to produce superoxide, both strains
establish similar fungal burdens reaching over 10
6 cfu in lungs by
day 8 (Figure 9B). In addition, Phox(2/2) mice are unable to
clear the normally sublethal infection and mice become moribund
at day 15 with nearly 10
8 fungal cfu per lung (Figure 9B).
Importantly, the kinetics and fungal burdens for SOD3(+) and
sod3D yeasts in the Phox(2/2) mice are statistically indistinguish-
able from each other. These infection data show the overall
significance of the role of host-derived reactive oxygen in limiting
Histoplasma infections. Additionally, they demonstrate that the
virulence attenuation of sod3D yeasts is due to reactive oxygen-
dependent killing by the host and further confirms Sod3 promotes
Histoplasma virulence in vivo by detoxifying host-derived reactive
oxygen.
Discussion
We show in this study that the fungal pathogen Histoplasma
capsulatum resists damage from antimicrobial ROS and demon-
strate that this ability directly contributes to Histoplasma virulence.
The extracellular superoxide dismutase Sod3 imparts resistance to
superoxide since Histoplasma strains lacking Sod3 are susceptible to
killing by superoxide anion and by macrophages and PMNs that
produce ROS. Although the repertoire of phagocyte anti-
Histoplasma defenses includes non-oxidative mechanisms such as
hydrolytic enzymes [32], defensins [32,33], and reactive nitrogen
[6,34], our use of an NADPH-oxidase inhibitor and Phox(2/2)
mutant mice demonstrate that killing of the sod3D mutant is
mediated by superoxide production. The protection of yeasts due
to Sod3 mechanistically explains previous studies that show
phagocytosis of Histoplasma yeasts by PMNs and activated
macrophages is accompanied by ROS production, yet the wild-
type yeasts remain viable [5,16–19].
Extracellular superoxide dismutases are appropriately posi-
tioned to combat host-derived ROS. Unlike peroxide, superoxide
is a charged molecule that does not readily cross cellular
membranes. This has important consequences for intracellular
pathogens. First, the lack of diffusion across membranes maintains
higher concentrations of superoxide within the phagosomal lumen.
Second, lack of diffusion into the fungal cell cytoplasm requires
superoxide defense mechanisms to be located extracellularly. The
Histoplasma Sod3 protein has an N-terminal signal sufficient to
direct it into the secretory pathway and a C-terminal signal that
promotes association with the cell surface. Cell-associated Sod3
may be covalently linked to the cell wall as has been shown for
some yeast cell wall proteins with GPI signals [24,25]. Consistent
with this, we have been unable to recover soluble Sod3 from cell
wall preparations after treatment with reducing agents, anionic
detergents, and glycanases (unpublished data). It is unknown if the
portion of Sod3 protein that is not associated with yeast cells
represents protein previously located at the cell surface and
subsequently shed or whether it is protein secreted directly into the
extracellular milieu. We suspect soluble Sod3 reflects insufficient
retention on the cell since deletion of the C-terminal GPI signal
shifts Sod3 from association with the cell into the soluble fraction.
Deletion of the GPI signal did not completely prevent association
of Sod3 with the cell, suggesting the existence of other unidentified
cell-association signals. Regardless, both soluble and cell-associat-
ed Sod3 are appropriately located extracellularly in order to
detoxify superoxide in the phagosomal lumen.
Our study is the first to demonstrate Histoplasma produces
extracellular superoxide dismutase activity and identifies its source
as Sod3. These results differ from earlier studies that failed to show
Histoplasma yeasts could dismute exogenously generated superoxide
in vitro [10,11]. A number of experimental differences likely
account for this discrepancy. In the earlier in vitro studies, nearly 4
times more superoxide were generated and 10-fold less yeast cells
were used as the potential superoxide dismutase source. In the
current study, the use of a more sensitive detection reagent for
superoxide (WST-1; [23,35]) allowed us to generate less superox-
ide which did not overwhelm the dismutase activity of the number
Figure 8. Lethal infection by Histoplasma requires Sod3
function. Kinetics of mouse survival after infection with a lethal dose
of Histoplasma yeasts. Wild-type C57BL/6 mice were intranasally
infected with 7610
6 SOD3(+) (OSU45), sod3D (OSU15), or sodD/SOD3
(OSU49) Histoplasma yeasts (n=8 per strain). Survival time of mice
infected with sod3D yeasts differs significantly from that of infections
with SOD3(+) and sodD/SOD3 (p,0.0001).
doi:10.1371/journal.ppat.1002713.g008
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corresponding loss of extracellular superoxide dismutase activity
provide further evidence of the ability of Sod3-producing
Histoplasma yeasts to destroy exogenous superoxide. While most
studies have agreed that Histoplasma yeasts trigger ROS release
from PMNs [5,13,16–19], studies failing to detect ROS produc-
tion [11] may have misinterpreted the results as lack of ROS
stimulation instead of rapid destruction of ROS. Our results show
that in the presence of efficient superoxide scavenging by Sod3,
phagocyte ROS levels rapidly return to baseline by 10 to
15 minutes resulting in a narrow window for detection (Figure 5C).
The susceptibility of sod3D yeasts to superoxide challenge in
vitro and their attenuated virulence show superoxide is one of the
major toxic oxidative compounds against which Histoplasma must
defend in vivo. Although superoxide can be dismuted to peroxide,
either through spontaneous or Sod3-catalyzed dismutation,
peroxide is not the toxic form of reactive oxygen responsible for
damaging the sod3D yeasts. As evidence of this, we show that yeasts
lacking Sod3 function are killed by superoxide, but do not exhibit
any increased sensitivity to peroxide (Figure 4A–B). Lack of
peroxide sensitivity may result from efficient destruction of
peroxide by Histoplasma yeasts since they also express an
extracellular catalase [36–38]. As an uncharged molecule,
peroxide can also diffuse into the yeast cell cytoplasm where
intracellular scavenging enzymes may also protect yeasts from
oxidative damage from peroxide. Alternatively, yeast viability may
rely on essential target molecules that are attacked specifically by
superoxide but not peroxide. The impact of exogenous peroxide
and the role of Histoplasma peroxide defenses await further genetic
tests with yeasts lacking catalase antioxidant factors.
The ability to tolerate or destroy host-generated reactive oxygen
is a fundamental characteristic of successful microbial pathogens.
Extracellular dismutation of superoxide is a capability shared by
Histoplasma and other intracellular pathogens of macrophages
including Mycobacterium tuberculosis [39], Salmonella spp. [40,41], and
Francisella tularensis [42].. A past study demonstrated that the
resistance of fungal pathogens to killing by PMNs distinguishes
primary from opportunistic pathogens; despite triggering ROS
release from PMNs, Histoplasma, Blastomyces, and Paracoccidioides
survived whereas Candida and Aspergillus cells were efficiently killed
[19]. Genome analyses of the dimorphic fungal pathogens
Blastomyces, Paracoccidioides, and Coccidioides identify proteins homol-
ogous to Histoplasma Sod3 and these proteins also have predicted
N-terminal signal peptides (data not shown). This suggests that,
like Sod3, they are extracellular superoxide dismutases that could
protect these fungal cells from ROS release during interaction with
host cells. The production of extracellular superoxide dismutases
thus appears to be a defining characteristic of primary pathogens
that are not effectively controlled by the innate immune system.
Extracellular superoxide dismutation typifies intracellular patho-
Figure 9. Sod3 facilitates infection through detoxification of host reactive oxygen. Kinetics of sublethal lung infection by Histoplasma in
animals competent for ROS production (A) or animals lacking the NADPH-oxidase function (B). Mice were intranasally infected with approximately
1610
4 SOD3(+) (OSU45) or sod3D (OSU15) Histoplasma yeasts. At 2, 4, 8, and 15 days post-infection, the fungal burden in lungs was determined by
quantitative platings for Histoplasma cfu. (A) Respiratory infection of Phox(+/+) mice isogenic to the p47
phox knock-outs. (B) Respiratory infection of
p47
phox knock-out (Phox(2/2)) mice. Each data point represents cfu counts per lung from an individual animal (n=3 per time point) and horizontal
bars represent the mean fungal burden. Non-significant (ns) or significant differences (* p,0.05, ** p,0.01) from animals infected with SOD3(+)
organisms is indicated above the respective columns. The actual inoculum dose is shown in graphs at day 0. The limit of detection is 100 cfu.
doi:10.1371/journal.ppat.1002713.g009
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involves engagement of and internalization into superoxide-
producing phagocytes.
A number of plant and human pathogenic fungal species
express multiple superoxide dismutases, which have been postu-
lated to impart virulence potential. However, the majority of the
identified Sods are intracellular enzymes (cytosolic or mitochon-
drial) and their loss causes sensitivity to intracellular oxidative
molecules. This suggests that the in vivo virulence attenuation of
fungi with deleted intracellular SOD genes may stem from their
impaired ability to alleviate superoxide stress arising from altered
metabolism imposed by growth in the host rather than insufficient
detoxification of host-derived superoxide. For example, Cryptococcus
gattii Sod1 and Sod2, Cryptococcus neoformans Sod1 and Sod2, and
Candida albicans Sod1, Sod2, and Sod3 are all intracellular Sods.
Deletion of their encoding genes reduces fungal virulence in vivo
but also increases sensitivity to pharmacologically-induced intra-
cellular oxidative stress or growth on respiration-requiring media
[43–46]. Cryptococcus neoformans sod1D mutants survive and replicate
within macrophages albeit at a slightly slower rate also consistent
with Sod1 functioning in reducing metabolic rather than host-
produced oxidative stress [47]. Whether virulence attenuation in
these mutants arises from failure to defend against host-produced
oxidative stress awaits testing in hosts unable to produce
superoxide. Data for the involvement of superoxide dismutases
in fungal infection of plants is based primarily on correlations with
SOD gene transcription during fungus-plant interaction [48–51],
but genetic evidence of the role of superoxide dismutase is largely
lacking or contradictory in the case of Botrytis Sod1 [52,53]. The
results of our study using Histoplasma strains deficient in Sod1 and
Sod3 demonstrate the spatial specificity of the Sod1 and Sod3
superoxide dismutases for internal and external (i.e., host-derived)
superoxide, respectively. Only growth of the Sod1-depleted strain,
but not Sod3-deficient yeasts, is impaired when intracellular
superoxide levels are increased (Figure 3). Conversely, only Sod3-
deficient but not Sod1-depleted yeasts are attenuated in virulence
in vivo (Figure 7 and Figure S4). Furthermore, the restoration of
Histoplasma sod3D mutant virulence in mice unable to produce
superoxide conclusively shows that Sod3 functions in detoxifica-
tion of superoxide generated by the host.
However, pathogenic potential is not solely attributable to
extracellular Sods and their ability to destroy toxic ROS. For
example, the opportunistic fungal pathogen Candida albicans
expresses at least two extracellular superoxide dismutases (Sod4
and Sod5) that are induced in response to oxidative stress and are
required for full virulence in mice [54,55]. Conflicting results exists
as to whether Sod5 affords some protection to Candida against
superoxide-dependent killing by phagocytes in vitro [54–56], and
one study shows Sod5 affects sensitivity to miconazole-induced
intracellular ROS [57]. Nonetheless, Candida is still effectively
controlled by innate immune cells. In short term viability assays,
we found PMNs kill nearly 80% of Candida yeasts (Figure 5A)
suggesting Candida Sod4 and Sod5 proteins are insufficient to
protect against the levels of superoxide generated by PMNs.
Resting and activated macrophages similarly killed Candida to a
large extent in our study (Figure 6A–B). Interestingly, Histoplasma
yeasts lacking Sod3 closely resemble Candida yeasts in their
susceptibility to in vitro superoxide and to phagocyte-derived
ROS, showing Histoplasma Sod3 contributes to the greater
resistance of Histoplasma to phagocyte killing and consequently to
Histoplasma’s ability to cause disease in immunocompetent hosts.
In addition to detoxification of ROS, the ability to minimize
stimulation of the phagocyte respiratory burst also contributes to
the pathogenic potential of fungi. Similar to Candida, Histoplasma
stimulates ROS production by PMNs and activated macrophages
(Figure 5C, Figure 6D, and [5,12,13,56]). However, the level of
ROS release triggered by sod3D mutant Histoplasma yeasts is less
than that caused by other phagocyte stimuli such as phorbol
myristate acetate and zymosan (data not shown). This may result
from decreased phagocyte recognition of Histoplasma yeasts since
the a-glucan polysaccharide in Histoplasma cell walls masks cell wall
b-glucans from the phagocyte b-glucan receptor Dectin-1 [58]. On
the other hand, Candida cell wall molecules are recognized by
multiple pattern recognition receptors [59] and Dectin-1 recogni-
tion of Candida enhances ROS production by phagocytes [60–63].
Despite the ability of Histoplasma Sod3 to destroy fungicidal
superoxide, host-generated ROS provides some limited control of
Histoplasma during the innate immune response and is critically
important for clearance of Histoplasma upon activation of immune
cells. IFNc treatment of macrophages primes host cells for ROS
production in response to Histoplasma yeasts [64] and addition of
TNFa further enhances ROS generation [12,13]. Pre-treatment of
macrophages with levels of IFNc and TNFa used in our study
enhance ROS production in response to stimuli while keeping nitric
oxide levels relatively low [65]. In vitro, activation of macrophages
can variably inhibit Histoplasma yeasts [13,64,66–68] while our
results indicate Sod3 protects Histoplasma yeasts against activated
macrophage ROS, at least in short term assays (up to 4 hours).
Rapid proliferation of both Sod3-producting and Sod3-deficient
Histoplasma in the lungs of mice lacking NADPH-oxidase function
highlights the critical importance of host ROS. Phox(+/+) mice,
compared to Phox(2/2) mice, restrict even SOD3(+) Histoplasma
yeasts, indicating the involvement of oxidative defense mecha-
nisms . While this restrains the infection to some degree, the innate
response is unable to clear the infection. Our results indicate that
Sod3 function is a major factor in protecting the yeasts from innate
immune cells and in promoting histoplasmosis (Figure 7C,
Figure 8, and Figure S3). Consistent with this early involvement
of ROS, yeasts lacking Sod3 function are rapidly killed during the
early phases of infection (Figure 7A and Figure 9A). Nonetheless,
the sod3D yeasts are not entirely cleared and in fact show some
proliferation of the fungal burden in lungs between days 4 and 8
(Figure 7A and Figure 9A). We suspect resting macrophages, the
infection of which by Histoplasma does not result in significant ROS
production (Figure 6, and [5,10–12]), provide a temporary refuge
for Sod3-deficient yeast. However, influx of CD4
+ T-cells and the
corresponding increase in IFNc in lungs after day 7 [69] promotes
clearance of sod3D yeasts through activation of macrophages and
enhancement of oxidative killing. Cytokine activation of macro-
phages in culture and their ability to kill sod3D yeasts support this
model (Figure 6B). Thus, Sod3 is an essential virulence factor that
protects Histoplasma yeasts from killing by ROS produced by the
host, particularly during the innate immune response to infection.
Materials and Methods
Ethics statement
This study was carried out in accordance with The National
Research Council’s Guide for the Care and Use of Laboratory
Animals, Public Health Service Policy on Humane Care and Use
of Laboratory Animals, and AAALAC accreditation guidelines.
The protocol was approved by the Ohio State University
Institutional Animal Care and Use Committee (protocol number:
2007A0241). Animal procedures were performed under anesthesia
as described below and all efforts were made to minimize suffering.
Human cells were obtained from healthy volunteers after
obtaining HIPAA research authorization and written informed
consent in accordance with the Declaration of Helsinki. The
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State University Biomedical Sciences Institutional Review Board
(protocol number 2008H0242) under Ohio State University’s
Office for Human Research Protections (Federalwide Assurance
number: 00006378).
Fungal strains and culture
Histoplasma capsulatum strains used in this study were derived from
thewild-typestrainG186A(ATCC26027)and arelisted inTable1.
Histoplasma yeasts were grown in Histoplasma-macrophage medium
(HMM; [70]) or modified 3M medium (85 mM NaCl, 1 mM
K2HPO4, 20 mM HEPES, 1.5% glucose, 15 mM (NH4)2SO4,
1m M M g 2SO4, 0.2 mM CaCl2, 15 mM glutamate, 350 mM
cysteine at pH 7.0; [70]) at 37uC. Liquid cultures were continuously
shaken (200 rpm) until late log/early stationary phase unless
otherwise indicated. For growth of uracil auxotrophs, media was
supplemented with uracil (100 mg/mL). Growth rate and growth
stage of strains were determined by measurement of liquid culture
turbidity at 595 nm. In some experiments media was supplemented
withparaquat (856177, Sigma) to a final concentrationof 5 mM and
10 mM to artificially raise the intracellular levels of superoxide. For
growth on solid media, HMM was solidified with 0.6% agarose and
supplemented with 25 mM FeSO4. Histoplasma yeasts were trans-
formed with linear plasmids by electroporation [71] and plated on
solid HMM to select Ura
+ transformants. For experiments with
defined numbers of yeasts, clumps of cells were removed by
centrifugation (1 minute at 50 rcf). For precise enumeration, yeast
cells were counted using a hemacytometer. The cap1D/cap1D
Candida albicans strain (used to prevent filamentous growth of
Candida albicans which would confuse accurate enumeration of cfu;
[72]) was grown in liquid YPD medium or on YPD solidified with
2% agar. Candida cells were enumerated by hemacytometer.
Generation of the sod3D mutant, SOD3-complemented,
and SOD1-RNAi strains
WU8 Histoplasma yeasts were transformed with the URA5(+)
plasmid pBY06 which contains a hygromycin resistance gene
flanked by 2 kb of sequence upstream and 2 kb of sequence
downstream of the SOD3 coding sequence. Hygromycin-resistant
transformants were grown in liquid HMM with uracil and
150 mg/mL hygromycin B, diluting the culture 20-fold when
stationary phase was reached. 3 passages in liquid culture were
performed after which yeast cells were plated on solid HMM
containing uracil, 150 mg/mL hygromycin B, and 1 mg/mL 5-
fluororotic acid (5-FOA) to counter-select retention of the knock-
out allele episomal molecule. Hygromycin-resistant, 5-FOA-
resistant colonies were picked and screened for the loss of the
SOD3 CDS by PCR. For complementation, the SOD3 gene was
amplified from wild-type G186A genomic DNA by PCR and
cloned into pCR468 replacing the gfp transgene. The pCR468
vector contains the histone-2B (H2B) promoter for high level
constitutive expression of transgenes. The sod3D mutant was
transformed either with the gfp- (pCR468) or SOD3-expression
vector (pBY09) and Ura
+ transformants selected to create uracil-
prototrophic strains. An isogenic strain with the wild-type SOD3
locus was also created by transformation of WU8 with the gfp-
expression vector (pCR468).
Depletion of Sod1 was achieved using RNAi. Nucleotides 212
to 787 of the SOD1 CDS were amplified by PCR and two copies
cloned in inverse orientation into the RNAi gfp-sentinel vector
pCR473 [26]. Linearized plasmids were transformed into OSU22,
a WU8-based strain that expresses a gfp transgene. Ura
+
transformants were screened for silencing of the GFP sentinel
using a modified UV transilluminator [73]. Transformants with
significant loss of GFP fluorescence were selected for analysis of
intracellular superoxide dismutase activity as described below.
Preparation of Histoplasma culture filtrate and cellular
lysate samples
Histoplasma yeasts were grown to late log/early stationary phase
in modified 3M medium. Yeast cells were removed by centrifu-
gation (5 minutes at 5000 rcf) and supernatants were filtered
through 0.2-mm pore polyethersulfone (PES) membranes. Culture
filtrates were concentrated and proteins exchanged into PBS
buffer by stir-cell based ultrafiltration using 10 kDa molecular
weight cut off PES membranes (Millipore) or centrifugal devices
Table 1. Histoplasma capsulatum strains.
Strain
a Genotype Other Designation
WU8
b ura5-32D
OSU13 ura5-32D sod3-3D::hph sod3D
OSU15 ura5-32D sod3-3D::hph/pCR468 [URA5, gfp:FLAG] sod3D
OSU22
c ura5-32D zzz::pCR482 [hph, gfp]
OSU45 ura5-32D/pCR468 [URA5, gfp:FLAG] SOD3(+)
OSU49 ura5-32D sod3-3D::hph/pBY09 [URA5, SOD3] sod3D/SOD3
OSU88 ura5-32D/pCR468 [URA5, gfp:FLAG] GFP:FLAG
OSU102 ura5-32D/pCR508 [URA5, SOD31–78:gfp:FLAG] Sod31–26:GFP:FLAG
OSU103 ura5-32D zzz::pCR482 [hph, gfp]/pCR464 [URA5] gfp(+)
OSU104 ura5-32D zzz::pCR482 [hph, gfp]/pCR473 [URA5, gfp-RNAi] gfp-RNAi
OSU105 ura5-32D zzz::pCR482 [hph, gfp]/pCR579 [URA5, gfp:SOD1-RNAi] gfp:SOD1-RNAi
OSU116 ura5-32D sod3-3D::hph/pCR601 [URA5, SOD31–78:FLAG:SOD379–693] sod3D/FLAG:SOD3
OSU117 ura5-32D sod3-3D::hph/pCR602 [URA5, SOD31–78:FLAG:SOD379–615] sod3D/FLAG:SOD3DGPI
aall strains were constructed in the G186A (ATCC# 26027) background.
buracil auxotroph of G186A (Marion CM, et al., 2006 [78]).
cGFP sentinel RNAi background (Edwards, et al. 2011 [26]).
doi:10.1371/journal.ppat.1002713.t001
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were determined by DC Lowry assay using ovalbumin as the
protein standard for comparison. Concentrated culture filtrates
were treated with 50 mM diethyldithiocarbamate (DDC) for
30 minutes to remove Cu
++ ions. DDC was removed by dialysis
against Tris-buffered saline (TBS) before assaying for superoxide
dismutase activity. Cu
++ ions were replenished by incubation of
Cu
++-depleted samples with 50 mM CuSO4 for 30 minutes and
subsequent dialysis against TBS.
Cellular lysates were prepared by collecting yeast cells from
liquid 3M cultures by centrifugation (5 minutes at 5000 rcf).
Cytosolic material was liberated from yeast cells by beating the
yeasts with 400 mm-diameter glass beads in PBS containing a
protease inhibitor cocktail (P2714, Sigma). Cellular lysate protein
concentrations were determined by DC Lowry assay using bovine
serum albumin as the protein standard.
Superoxide dismutase assay
Detection of superoxide dismutase activity was based on
depletion of superoxide as determined by the superoxide-
dependent reduction of the water soluble tetrazolium dye WST-
1 (Dojindo Molecular Technologies, [23,35]). Superoxide was
generated in vitro from hypoxanthine using xanthine oxidase
(X4500, Sigma). Reactions were performed in a solution consisting
of 50 mM Tris pH 8.0, 100 mM hypoxanthine, 5 mU/mL
xanthine oxidase, and 100 mM WST-1 to which variable amounts
of Histoplasma samples were added. WST-1 reduction over time at
25uC was monitored by absorbance at 438 nm using a Synergy 2
plate reader (BioTek). The inhibition of WST-1 reduction was
determined by subtracting the value of WST-1 reduction in each
sample from that of reactions with buffer alone (corresponding to
100% WST-1 reduction). For assays not comparing cell-associated
and soluble activities, culture filtrate samples were normalized to
5 mg total protein in a total volume of 200 mL and the kinetics of
WST-1 reduction determined. For experiments comparing cell-
associated and soluble superoxide dismutase activity, 1610
8 cells
(estimated by OD600 readings without removal of clumped yeast)
were collected by centrifugation and resuspended in a volume of
PBS equal to the volume of culture filtrate removed. Soluble
superoxide dismutase samples were obtained using the volume of
culture filtrate equivalent to that of 1610
8 Histoplasma yeast cells.
Cell-free samples were concentrated and buffer-exchanged into
PBS by ultrafiltration. Equivalent proportions of cells or culture
filtrates were added to the superoxide generating system in a final
volume of 400 mL. After 12 minutes with shaking (1000 rpm),
samples were centrifuged to remove cells, 200 mL clarified sample
recovered and the WST-1 reduction determined by end-point
absorbance at 438 nm. The proportion of superoxide dismutase
activity in culture filtrate or cell-associated samples was deter-
mined as the fraction of total inhibition of WST-1 reduction
relative to the respective buffer controls.
Construction and analysis of strains expressing variant
Sod3 proteins
Nucleotides 1 to 78 of the SOD3 CDS, encoding the first 26
amino acids of the Sod3 protein, were amplified by PCR and
inserted in frame in front of gfp with a C-terminal FLAG epitope.
Constructs were cloned behind the Histoplasma H2B promoter in a
URA5(+) expression vector (pCR468) to make vector pCR508.
Linearized pCR508 and pCR468 plasmids were transformed into
Histoplasma strain WU8. Culture filtrates and yeast cells were
collected from liquid cultures of Ura
+ transformants. 5 mg of total
culture filtrate and cellular lysate proteins were screened for the
FLAG epitope by immunoblotting with an anti-FLAG antibody
(F1804, Sigma) and for a-tubulin with the anti-tubulin antibody
(B512, Sigma).
For construction of Sod3 proteins truncated from the C-
terminus, a nucleotide sequence encoding the FLAG epitope was
inserted before nucleotide 79 of the SOD3 CDS. Downstream
SOD3 sequence ended at either nucleotide 615 or 693 of the
cDNA. Fragments were amplified and spliced together by PCR.
Fusion proteins were directed into the secretory pathway by
insertion of sequence encoding the Sod3 signal peptide (nucleo-
tides 1 to 78, encoding the first 26 amino acids) at the 59 end.
Constructs were cloned into the Histoplasma H2B-promoter
transgene expression vector (pCR468) to generate plasmids
pCR601 and pCR602. Linearized plasmids were transformed
into OSU13 and Ura
+ transformants assayed for cell-associated
and cell-free soluble superoxide dismutase activities. Statistical
significance was determined by one-tailed Student’s t-tests.
Immunoblotting for the FLAG epitope in culture filtrates was
performed by deglycosylating culture filtrate proteins with
PNGaseF (NEB) for at least 12 hours prior to separation of
proteins by SDS-PAGE and immunoblotting with the anti-FLAG
antibody. Immunoblot signals were quantified using ImageJ
software (http://rsbweb.nih.gov/ij/).
Determination of susceptibility to superoxide
For determination of superoxide susceptibility, Histoplasma or
Candida yeast cells were collected from log-phase liquid cultures
and 1610
5 cells were incubated in a superoxide-generating system
consisting of 50 mM Tris pH 8, 100 mM hypoxanthine, and
increasing amounts of xanthine oxidase (X4500; Sigma) in a total
volume of 500 mL in wells of a 24-well tissue culture plate. Yeasts
were incubated for 4 hours at 37uC with shaking (200 rpm) in a
humidified chamber. After incubation, yeasts were removed and
serial dilutions plated on solid media to determine viable fungal
colony forming units (cfu). For determination of peroxide
susceptibility, 1610
5 yeast cells were incubated in HMM with
increasing amounts of hydrogen peroxide (0 to 4 mM). Aliquots
were removed at 4 hours and serial dilutions plated on solid media
to determine viable cfu. The concentration of the hydrogen
peroxide stock solution was determined immediately before use by
spectrophotometric absorbance at 240 nm [74]. Survival was
statistically compared between strains using one-tailed Student’s t-
tests.
PMN isolation and infection
PMNs were isolated from human blood samples obtained by
venipuncture of healthy volunteers [75,76]. 10 mL venous blood
were collected into syringes containing 250 U heparin and diluted
back 2-fold in 0.9% saline solution. 10 mL of blood suspension
was layered onto 4.5 mL Ficoll-Paque PLUS and PMNs were
recovered by density sedimentation (40 minutes at 400 rcf at
18uC). Red pellets were harvested and suspended in 6 mL of 0.9%
saline before the addition of 6 mL of 3% Dextran500. Tubes were
gently mixed and incubated at 4uC for 20 minutes. The upper
layer was transferred to a new tube, and cells were collected by
centrifugation (15 minutes at 800 rcf at 4uC). Residual erythro-
cytes were lysed by suspending pellets in cold H2O and gently
mixing for 25 seconds before restoring isotonicity by adding an
equal volume of 1.8% saline solution. Recovered cells were
washed and suspended in Hanks buffered saline solution (without
Mg
++ or Ca
++) and cells enumerated by hemacytometer. Cell
viability was determined using trypan blue. Autologous serum was
prepared from separate blood samples following coagulation.
PMNs were seeded into 96-well tissue culture plates at 2610
5 cells
per well in DMEM with 10% autologous serum and cells were
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For infection, 2610
4 Histoplasma or Candida yeast cells were added
to the PMNs. PMNs and fungal cells were co-cultured at 37uCi n
5% CO2/95% air. For inhibition of the NADPH-oxidase, 10 mM
diphenylene iodinium (DPI;43088, Sigma) was added to PMNs
20 minutes before infection and maintained throughout the co-
culture. At specified times following infection, the culture medium
was removed and PMNs lysed by the addition of sterile water and
thoroughly scraping wells with a pipette tip. Cell lysates were
combined with the removed culture medium and serial dilutions
plated to determine viable fungal cfu counts. Yeast survival was
compared using one-tailed Student’s t-tests. Parallel cultures of
PMNs, with and without DPI, were used to score PMN viability
during the course of the assay. PMN viability was determined by
exclusion of trypan blue. 100 cells were scored for each of seven
fields by brightfield microscopy (for a total of 700 cells). For
luminescence assays PMNs were collected and seeded at 2610
5
cells per well in 96-well plates. To measure production of ROS,
the medium was replaced with luminescence buffer (115 mM
NaCl, 5.9 mM KCl, 1.2 mM MgCl2, 1.2 mM NaH2PO4,
2.5 mM CaCl2,5 0 mM luminol, 25 mM NaHCO3,1 0 m M
glucose at pH 7.4) containing 2610
5 yeasts. In some assays
10 mM DPI (diphenylene iodinium) was also added to inhibit the
NADPH-oxidase. Luminescence of wells was read every 2 minutes
at 37uC using a Wallac Victor plate reader.
Macrophage isolation and infection
Unelicited peritoneal macrophages were obtained by peritoneal
lavage of C57BL/6 mice (NCI) according to standard procedures
[77]. Following euthanasia, 10 mL PBS were injected into the
peritoneum and the peritoneum gently massaged for 1 minute.
Peritoneal cells were recovered by aspiration using a 10 mL
syringe with an 18-gauge needle inserted into a small incision.
Peritoneal cells were collected from the lavage fluid by centrifu-
gation (10 minutes at 700 rcf at 4uC). Cells were resuspended in
DMEM with 10% fetal bovine serum and enumerated by
hemacytometer. Macrophages were recovered by adherence to
plastic for 12 hours and removal of non-adherent cells. 1610
5
macrophages were seeded into each well of a 96-well tissue culture
plate. 100 U murine IFNc and/or 10 U murine TNFa (Biole-
gend) were added to wells for 24 hours at 37uCi n5 %C O 2/95%
air for activation of macrophages. For infection, 2610
3 Histoplasma
or Candida yeast cells were added to the macrophages. Macro-
phages and yeast cells were co-cultured at 37uCi n5 %C O 2/95%
air. In some wells, 10 mM DPI was added to inhibit the NADPH-
oxidase. At incremental times post-infection, the culture medium
was removed and macrophages lysed by addition of water. The
lysate and removed culture medium were combined and serial
dilutions plated on solid media for enumeration of viable fungal
cfu. Yeast survival was compared by one-tailed Student’s t-tests.
Parallel cultures of macrophages, with and without DPI, were used
to score macrophage viability during the course of the assay.
Macrophage viability was determined by exclusion of trypan blue.
100 cells were scored for each of seven fields by brightfield
microscopy (for a total of 700 cells). For luminescence experiments
macrophages were harvested as described above and 1610
5
macrophages were added to each well of a 96-well plate. ROS
production was determined by replacing the medium with
luminescence buffer containing 1610
5 yeasts. Luminescence of
wells was measured every 2 minutes at 37uC.
In vivo virulence determination
C57BL/6 mice (NCI or Harlan) were infected with Histoplasma
yeasts by intranasal delivery of 1610
4 to 2610
4 yeast cells.
Histoplasma yeast cells were collected from exponentially growing
liquid cultures and enumerated by hemacytometer. Actual cfu in
the inocula were determined by plating serial dilutions. At 4, 8, 12,
16, and 20 days post infection, mice were euthanized and lungs
and spleens collected. Lung and spleen tissues were homogenized
in 5 mL and 3 mL HMM, respectively, and serial dilutions of the
homogenates plated on solid HMM to determine the fungal
burden in each organ. For determination of virulence in mice
lacking the phagocyte oxidase, p47 knock-out mice (line 4227,
Taconic) or isogenic wild-type mice (line C56BL/6N, Taconic)
were infected intranasally with 1610
4 to 2610
4 Histoplasma yeast
cells and tissues harvested at 2, 4, and 8 days post-infection. To
prevent bacterial infections during the assay time course, 0.2 mg/
mL enrofloxacin (Bactrim) and 0.3 mg/mL tetracycline were
added to the drinking water and mice were housed on non-
abrasive Alpha-dri bedding (Shepherd Specialty Papers). Mean cfu
counts were compared between infections by one-tailed Student’s
t-test for statistical significance.
For histology analyses, mice were intranasally infected with
1610
4 to 2610
4 yeast cells. After 4 and 8 days, lungs were
removed, perforated with a 25-gauge needle, and fixed with 5%
formalin in phosphate buffered saline. Lung sections were stained
with hematoxylin and eosin and examined and interpreted by a
board-certified pathologist (Comparative Pathology and Mouse
Phenotyping Facility, Ohio State University College of Veterinary
Medicine).
For mouse survival assays, mice were intranasally infected with
7610
6 Histoplasma yeasts. Mice were monitored daily for survival,
weight loss, and symptoms of disease. Mice were determined to be
moribund if they demonstrated extreme lethargy, lateral recumb-
ence, or greater than 25% reduction in weight. Statistical analyses
were performed using the log-rank test.
Supporting Information
Figure S1 Increasing amounts of xanthine oxidase in-
creasetheamountofsuperoxideproduced.(A)Pr od uc ti o nof
superoxide by increasing amounts of xanthine oxidase (XOD) with
hypoxanthine. A two-fold dilution series of xanthine oxidase was
added to 100 mM hypoxanthine and the superoxide produced was
detected by reduction of WST-1. WST-1 reduction was monitored
over time by absorbance at 438 nm. Data points represent the mean
value of triplicate samples. (B) Linear relationship between the
amount of xanthine oxidase and the superoxide produced. The
amount of WST-1 reduced by superoxide in 8 minutes was
determined for each concentration of xanthine oxidase tested. A
linear curve was fit to the line (R-squared value=0.988).
(PDF)
Figure S2 Treatment with DPI does not affect phagocyte
viability. Human PMN (A) and murine peritoneal macrophage
(B) viability following sustained treatment with 10 mM dipheny-
lene iodinium (DPI). Relative phagocyte viability was determined
by microscopy of cells plated in chambered slides as cytosolic
exclusion of trypan blue (n=700 cells scored as 7 objective fields
with 100 cells per field). Time points monitored correspond to the
times of initial addition of DPI (220 minutes), time of addition of
yeast (0 minutes), and time points post-infection (60 minutes and
240 minutes). Error bars represent standard deviations. No
significant differences between DPI-treated and untreated cell
viability were found at any time point (p.0.05).
(PDF)
Figure S3 Lungs infected with Sod3-deficient Histoplas-
ma yeast have reduced inflammation. Histology of murine
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C57BL/6 mice were intranasally infected with approximately
1610
4 SOD3(+) (OSU45), sod3D (OSU15) or sodD/SOD3 (OSU49)
Histoplasma yeasts. At 4 days (A) or 8 days (B) post-infection, lungs
were removed, fixed in 5% formalin, and sections stained with
hematoxylin and eosin. Representative images are shown. Scale
bars represent 1 mm.
(PDF)
Figure S4 Intracellular Sod1 function is dispensable for
Histoplasma virulence. Kinetics of sublethal lung infection
with Histoplasma yeasts. Wild-type C57BL/6 mice were intrana-
sally infected with approximately 2610
4 gfp-RNAi (OSU104) or
gfp:SOD1-RNAi (OSU105) Histoplasma yeasts. The fungal burden
in lungs was determined by quantitative platings for Histoplasma cfu
at the indicated times representing progressing infection. Each
data point represents cfu counts per lung from an individual
animal (n=4 per time point) and horizontal bars represent the
mean fungal burden. No significant differences (ns) in fungal
burden are detected between infections with the SOD1-proficient
strain (gfp-RNAi) and the SOD1-depleted strain (gfp:SOD1-RNAi).
The actual inoculum dose is shown in graphs at day 0. The limit of
detection is 100 cfu.
(PDF)
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